Trial intelligence / Profile preview

Topical mitomycin C for pediatric caustic esophageal stricture after endoscopic dilatation

ACTRN12612000683831Phase 3Completed

Sponsor
Ain Shams University
Start
Jan 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, double-blind trial of mitomycin c in Esophageal stricture (2 arms), sponsored by Ain Shams University. Primary endpoint: Complete resolution of dysphagia. Started Jan 2008; status: completed.

02

Drugs

mitomycin c
03

Conditions

Esophageal stricture

Beyond the preview

Go deeper on ACTRN12612000683831.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12612000683831.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call